insights_auto
Why is EYPT up 2,54%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
3,23 $
arrow_upward
+2,54%(+0,080) 1D
6 հոկ, 11:34:07 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,18 $
High
3,29 $
Low
3,08 $
Mkt. cap
289,10 մլն
Avg. vol.
3,63 մլն
Volume
470,90 հզր
52-wk high
19,11 $
52-wk low
3,05 $
EPS
-3,74 $
Beta
1,67
Shares outstanding
86,21 մլն
No. of employees
214
Open
3,18 $
High
3,29 $
Low
3,08 $
Mkt. cap
289,10 մլն
Avg. vol.
3,63 մլն
Volume
470,90 հզր
52-wk high
19,11 $
52-wk low
3,05 $
EPS
-3,74 $
Beta
1,67
Shares outstanding
86,21 մլն
No. of employees
214
News stories
From web sources and news partners
AD HOC NEWS
·
7 ժամ առաջ
EyePoint Pharmaceuticals stock fell 3.08 percent as LUCIA nears
Investor's Business Daily
·
1 ամիս առաջ
The Surprising Reason This Biotech Just Plummeted 67%
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersՈւոթերթաուն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiteeyepoint.bio